Skip to main content
OpenTrials

Clinical trial condition

GastroEsophageal Cancer

Explore clinical trials studying GastroEsophageal Cancer. Study availability and eligibility vary by location and protocol.

62 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

GastroEsophageal Cancer trial results

Completed

Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers

NCT03798626

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +25 more
Locations
  • University of California LA Los Angeles, California, United States
  • WA Uni School Of Med St Louis, Missouri, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • Novartis Investigative Site Melbourne, Victoria, Australia
View all 34 locations
View Trial Details
Completed

A Clinical Study To Evaluate Camrelizumab (SHR-1210) Plus Capecitabine and Oxaliplatin Followed by Sequential Treatment With Camrelizumab Plus Apatinib Mesylate in Advanced or Metastatic Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJ) Without Prior Systemic Therapy

NCT03813784

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +7 more
Locations
  • Beijing Cancer Hospital, Peking University Beijing, Beijing Municipality, China
View Trial Details
Completed

A Study of DKN-01 in Combination With Paclitaxel or Pembrolizumab

NCT02013154

Conditions
Adenocarcinoma of the Gastroesophageal Junction, Carcinoma, Carcinoma, Squamous Cell, +15 more
Locations
  • Cedars Sinai Medical Care Foundation Los Angeles, California, United States
  • Smilow Cancer Hospital at Yale - New Haven New Haven, Connecticut, United States
  • Northwestern University Chicago, Illinois, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Epidemiological Characteristics of Gastric and Pancreatic Cancers in Latin America

NCT05924789

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +12 more
Locations
  • Instituto de Oncología San Gerónimo Santa Fe, Santa Fe Province, Argentina
  • ÉTICA Clínica AMO - Assistência Multidisciplinar em Oncologia Salvador, Estado de Bahia, Brazil
  • HMV - Hospital Moinhos de Vento Porto Alegre, Rio Grande do Sul, Brazil
  • CEPON - Centro de Pesquisas Oncológicas Florianópolis, Santa Catarina, Brazil
View Trial Details
Completed

First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours

NCT04504669

Conditions
Adenocarcinoma, Advanced Solid Tumours, Breast Diseases, +48 more
Locations
  • Research Site Baltimore, Maryland, United States
  • Research Site St Louis, Missouri, United States
  • Research Site Huntersville, North Carolina, United States
  • Research Site Franklin, Tennessee, United States
View all 13 locations
View Trial Details
Completed

Modified FOLFOX Plus/Minus Nivolumab and Ipilimumab vs. FLOT Plus Nivolumab in Patients With Previously Untreated Advanced or Metastatic Gastric Cancer

NCT03647969

Conditions
Adenocarcinoma of the Stomach, GastroEsophageal Cancer
Locations
  • Klinikum St. Marien Amberg Amberg, Germany
  • Klinikum Aschaffenburg Aschaffenburg, Germany
  • HELIOS Klinikum Bad Saarow Bad Saarow, Germany
  • Charité CVK Berlin, Germany
View all 27 locations
View Trial Details

Related conditions